Form 8-K - Current report:
SEC Accession No. 0001370053-25-000103
Filing Date
2025-11-26
Accepted
2025-11-26 16:00:38
Documents
58
Period of Report
2025-11-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K anab-20251126.htm   iXBRL 8-K 26942
2 EX-99.1 a11-26x25publicversionve.htm EX-99.1 77329
7 a11-26x25publicversionve001.jpg GRAPHIC 114975
8 a11-26x25publicversionve002.jpg GRAPHIC 152256
9 a11-26x25publicversionve003.jpg GRAPHIC 137712
10 a11-26x25publicversionve004.jpg GRAPHIC 178667
11 a11-26x25publicversionve005.jpg GRAPHIC 154991
12 a11-26x25publicversionve006.jpg GRAPHIC 135151
13 a11-26x25publicversionve007.jpg GRAPHIC 129135
14 a11-26x25publicversionve008.jpg GRAPHIC 151560
15 a11-26x25publicversionve009.jpg GRAPHIC 155095
16 a11-26x25publicversionve010.jpg GRAPHIC 159494
17 a11-26x25publicversionve011.jpg GRAPHIC 158551
18 a11-26x25publicversionve012.jpg GRAPHIC 165064
19 a11-26x25publicversionve013.jpg GRAPHIC 156655
20 a11-26x25publicversionve014.jpg GRAPHIC 150217
21 a11-26x25publicversionve015.jpg GRAPHIC 157441
22 a11-26x25publicversionve016.jpg GRAPHIC 167014
23 a11-26x25publicversionve017.jpg GRAPHIC 160971
24 a11-26x25publicversionve018.jpg GRAPHIC 159047
25 a11-26x25publicversionve019.jpg GRAPHIC 156498
26 a11-26x25publicversionve020.jpg GRAPHIC 154716
27 a11-26x25publicversionve021.jpg GRAPHIC 160917
28 a11-26x25publicversionve022.jpg GRAPHIC 161467
29 a11-26x25publicversionve023.jpg GRAPHIC 154527
30 a11-26x25publicversionve024.jpg GRAPHIC 163345
31 a11-26x25publicversionve025.jpg GRAPHIC 160174
32 a11-26x25publicversionve026.jpg GRAPHIC 144554
33 a11-26x25publicversionve027.jpg GRAPHIC 163957
34 a11-26x25publicversionve028.jpg GRAPHIC 162200
35 a11-26x25publicversionve029.jpg GRAPHIC 169077
36 a11-26x25publicversionve030.jpg GRAPHIC 163726
37 a11-26x25publicversionve031.jpg GRAPHIC 123011
38 a11-26x25publicversionve032.jpg GRAPHIC 132175
39 a11-26x25publicversionve033.jpg GRAPHIC 147020
40 a11-26x25publicversionve034.jpg GRAPHIC 161472
41 a11-26x25publicversionve035.jpg GRAPHIC 164370
42 a11-26x25publicversionve036.jpg GRAPHIC 159077
43 a11-26x25publicversionve037.jpg GRAPHIC 134948
44 a11-26x25publicversionve038.jpg GRAPHIC 149014
45 a11-26x25publicversionve039.jpg GRAPHIC 137154
46 a11-26x25publicversionve040.jpg GRAPHIC 153969
47 a11-26x25publicversionve041.jpg GRAPHIC 149422
48 a11-26x25publicversionve042.jpg GRAPHIC 162072
49 a11-26x25publicversionve043.jpg GRAPHIC 137718
50 a11-26x25publicversionve044.jpg GRAPHIC 92576
  Complete submission text file 0001370053-25-000103.txt   9470550

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20251126.xsd EX-101.SCH 2058
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20251126_def.xml EX-101.DEF 8934
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20251126_lab.xml EX-101.LAB 30000
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20251126_pre.xml EX-101.PRE 20656
60 EXTRACTED XBRL INSTANCE DOCUMENT anab-20251126_htm.xml XML 2914
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 251529947
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)